H9c2心肌细胞多巴胺受体的表达

为明确H9c2心肌细胞是否能够表达多巴胺受体（dopamine receptor,DR）,应用RT-PCR和Westernblot-ting分别检测H9c2心肌细胞和SD成年雌鼠左心室心肌组织中,DR的两种亚型,D1DR和D4DR的表达.结果发现,H9c2心肌细胞可在mRNA和蛋白水平上表达出与SD大鼠心肌组织相同的产物.这说明能以H9c2心肌细胞为研究材料,进一步深入研究心肌D1DR和D4DR基因的表达调控机制以及心肌DR的功能.     

人肺巨细胞癌蛋白质组的二维电泳和计算机图象分析

为优化用于蛋白质组研究的二维电泳技术和计算机图象分析技术 ,以及初步分析比较与肿瘤细胞转移相关的蛋白质 ,以人肺巨细胞癌 (PLA- 80 1 - D、C)高、低转移株作为研究对象 ,应用 IPG-phor进行第一向等电聚焦 ,随后 ,在 Protein IPG conversion Kit上进行垂直 SDS- PAGE的分离 .利用光密度仪对银染的凝胶扫描 ,通过 PDQuest软件进行蛋白斑点检测和配比 .结果表明 :(1 )应用 IPGphor,采用样品直接加入重泡胀溶液的形式 ,增大了溶解性 ,缩短聚焦时间、增大样品负荷量 (分析型 ) ,提高了分辨率 .(2 )比较宽 (p H=3～ 1 0 L)、窄 (p H=4～ 7L)范围 IPG胶条 ,窄 p H范围的 IPG胶条具有较高的分辨率 .(3)比较 PLA- 80 1 - C、D细胞蛋白图谱之间的差异 ,其相关系数为 0 .7339± 0 .0 2 91 ;仅在 PLA- 80 1 - C株出现的蛋白为 1 79个 .     

nm23-H1-GFP融合蛋白在人肺癌细胞株中的表达及其对肿瘤细胞体外侵袭能力的影响

研究 nm2 3- H1在肿瘤细胞中的定位及其对肿瘤细胞体外侵袭能力的影响 .用 RT- PCR方法检测人高和低转移肺巨细胞癌细胞株 95 D和 95 C中 nm2 3- H1的表达 ;利用分子克隆技术构建nm2 3- H1 -绿色荧光蛋白 ( GFP)融合基因表达质粒 ( p NM2 3- GFP) ,经脂质体转染将此质粒导入95 D和 95 C细胞中 ,筛选高荧光强度的克隆 ,用 Boyden小室模型检测其体外侵袭能力的变化 .结果显示 nm2 3- H1在 95 C细胞中的表达比 95 D高 .95 D细胞中表达的 nm2 3- H1 c DNA未发生突变 .表达的 nm2 3- H1 - GFP融合蛋白位于细胞的胞浆近胞膜处 .转染 p NM2 3- GFP质粒的 95 D和 95 C细胞体外侵袭能力明显比对照组低 .这些提示 nm2 3- H1高表达能明显降低肿瘤细胞体外侵袭能力 .     

NDRG2 和ZC3H12D在大鼠急性肺损伤中的表达及其相关性的研究

目的:通过建立LPS诱导的大鼠急性肺损伤模型,观察大鼠肺组织中N-myc下游调节基因2(NDRG2)和具有CCCH锌指结构域的蛋白质12d(ZC3H12D)表达水平的变化来讨论二者相互作用的机制。方法:40只健康成年雄性SD大鼠随机分成对照组、LPS注射60 min、120 min和180 min组,获取各组大鼠肺组织,行湿干重比值(W/D)检测、ELISA检测、病理(HE)检测确定肺损伤模型是否建立成功;免疫组化、RT-PCR和Western-blot对NDRG2和ZC3H12D在m RNA水平和蛋白水平进行检测。结果:各LPS损伤组与对照组相比,W/D比值显著升高,180 min组比值最高,为5.68±0.52(P0.05),血清和肺匀浆中TNFα和IL-1β含量明显增加(P0.05);损伤组肺泡壁增宽,炎细胞浸润明显;肺组织NDRG2和ZC3H12D在m RNA水平和蛋白水平的表达都呈相降低后回升的趋势,180 min组NDRG2和ZC3H12D,蛋白含量分别为对照组的0.37和0.44倍(P0.05)。结论:LPS诱导的大鼠急性肺损伤可同时下调肺组织中NDRG2和ZC3H12D的表达,并且NDRG2和ZC3H12D具有潜在的相关性,提示两者可能存在互相调节的机制,并通过调节NF-κB通路对肺损伤的大鼠起保护作用。     

黄芪皂苷IV对H2O2诱导的心肌细胞凋亡的保护作用

目的:探讨黄芪皂苷对H2O2诱导的心肌细胞凋亡的保护作用.方法:以H2O2诱导SD大鼠心肌损伤细胞模型为基础,用黄芪皂苷IV预处理进行干预.MTT法检测不同时段细胞凋亡情况,Western blot和RT-PCR检测24h时段Cyclin D1蛋白和mRNA表达水平.结果:H2O2对SD大鼠心肌细胞的损伤呈时间依赖性.H2O2可显著诱导SD大鼠心肌细胞凋亡.而这一作用可被黄芪皂苷IV显著抑制.结论:黄芪皂苷IV对H2O2诱导的SD大鼠心肌细胞损伤有明显保护作用.     

DNA损伤和修复中的H2AX磷酸化及其在生殖相关细胞中的作用

H2AX是组蛋白H2A家族常见的变体之一，H2AX磷酸化是指哺乳动物细胞中的组蛋白H2AX在其C端第139位丝氨酸上发生磷酸化修饰形成磷酸化组蛋白H2AX(histone H2AX phosphorylation,γH2AX)的过程。目前，γH2AX的检测方法主要有免疫荧光法、流式细胞术、免疫印迹法。γH2AX是DNA损伤尤其是DNA双链断裂(DNA double-strand breaks,DSB)或DNA修复的标志物，已经被应用到医学相关领域，如放射性DNA损伤的检测、癌症的辅助诊断以及预后监测。此外，γH2AX在检测生殖细胞中的DNA损伤及修复和维持胚胎干细胞的自我更新中有重要意义。检测γH2AX水平已成为评价生殖细胞和干细胞质量的重要方法。本文将从H2AX及其家族的生物学特征、γH2AX的检测方法、DNA损伤与修复中的H2AX磷酸化及其在生殖相关细胞中的应用等角度对γH2AX研究进展进行总结和探讨。     

兴安落叶松天然林生物量及生产力的研究

 依据生物量标准木237株、解析木814株以及355块标准地实测材料对内蒙古大兴安岭林区三个气候区兴安落叶松天然幼、中龄林的生物量和净初级生产力进行了分析比较。结果表明,兴安落叶松天然林的生物产量明显受热量带的影响。残差分析证实了VAR模型lnW =lna+blnD+cD或lnW=lna+bln D2H+CD2H在估测兴安落叶松天然林生物量方面的应用价值,该模型对相对生长率随D或D2H呈线性变化的情况更为适合。本文还给出了各气候区适宜的林分密度和叶面积指数范围。     

生物分子的纳米粒子标记和检测技术

生物分子的标记和检测一直是生物分析领域的重要内容 .近年来 ,纳米材料与生物检测技术的结合 ,使得生物分子的检测有了重要的发展 ,这一交叉学科现已成为生物分析领域最具活力的研究方向 .对近期出现的新型纳米粒子标记物的性质、检测原理、特点和应用进行了评述 ,并分析了用该标记物进行分析的可能发展方向     

应用IdentifilerTM系统对湖南人群中OL等位基因的观察与分析

应用IdentifilerTM系统和ABI310型遗传分析仪,对湖南人群中3 423例无关个体进行基因分型,筛选出OL等位基因,并对其分布及构成进行分析.结果显示在3 423例个体基因分型中,发现12种OL等位基因,分布于D13S317、D19S433、D21S11、D3S1358、D7S820和FGA等6个基因座,各基因座OL等位基因的种类数目为1～3个,位点频率为0.292‰～9.641‰.通过以上研究,可对IdentifilerTM系统群体遗传多态性数据进行有效的补充和完善,从而使其更好地应用于人类生物学、法医遗传学等领域.     

胰腺癌潜在肿瘤标志物的探索及在胰腺癌中的应用

目的:探索胰腺癌新的潜在标志物,建立夹心法ELISA体系,并初步应用于胰腺癌患者的血清检测。方法:应用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF-MS)技术对胰腺癌患者术前后血清进行分析,提纯分析差异蛋白并命名为DAP44,通过杂交瘤技术制备出抗DAP44单克隆抗体,用HRP标记法标记抗体,间接ELISA法检测抗体滴度,用制备出的抗体对胰腺癌组织和癌旁组织进行组化染色,采用夹心ELISA(DAS-ELISA)法制备抗DAP44检测试剂盒,检测胰腺癌病人和正常人血清DAP44值,比较两者差异。结果:对差异蛋白进行肽段测序和生物信息分析,并融合了3株能稳定分泌抗DAP44单克隆抗体的杂交瘤细胞(2D6H5,1E4D6,5B8H12),3株杂交瘤细胞分泌的抗体效价均在107以上,通过抗体配对筛选确定以2D6H5为包被抗体,1E4D6为酶标抗体时,DAS-ELISA法敏感性最高。两株抗体组化染色结果显示:癌组织DAP44表达量远高于癌旁。DAS-ELISA法标准曲线线性范围在0.78-25 ng/mL,检测下线为0.78 ng/mL,此方法检测到的胰腺癌病人和正常人血清DAP44平均含量分别为19.707±1.464和10.653±2.221,两者之间有统计学差异(P0.001)。结论:DAP44可能作为潜在的胰腺癌肿瘤标志物,建立的抗DAP44 DAS-ELISA法体系能够初步用于胰腺癌的临床诊断和疗效评估指标。     

Denaturing high-performance liquid chromatography in the detection of ABCA1 gene mutations in familial HDL deficiency

Mutations in the ABCA1 gene are the cause of familial high density lipoprotein deficiency (FHD). Because these mutations are spread over the entire gene, their detection requires the sequencing of all 50 exons. The aim of this study was to validate denaturing high-performance liquid chromatography (DHPLC) in mutation detection as an alternative to systematic sequencing. Exons of the ABCA1 gene were amplified using primers employed for sequencing. Temperatures for DHPLC were deducted from a software and empirically defined for each amplicon. To assess DHPLC reliability, we tested 30 sequence variants found in FHD patients and controls. Combined DHPLC and sequencing was applied to the genotyping of new FHD patients. Most of the amplicons required from two to five temperature conditions to obtain partially denatured DNA over the entire amplicon length. Twenty-nine of the variants found by sequencing were detected by DHPLC (97% sensitivity). The detection of the last variant (in exon 40) required different primers and amplification conditions. DHPLC and sequencing analysis of new FHD patients revealed that all amplicons showing a heteroduplex DHPLC profile contained sequence variants. No variants were detected in amplicons with a homoduplex profile. DHPLC is a sensitive and reliable method for the detection of ABCA1 gene mutations.     

Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations

Alterations of the mitochondrial DNA (mtDNA) are implicated in various pathological conditions. In this study, we used denaturing high performance liquid chromatography (DHPLC) as a method to rapidly screen the entire mtDNA for mutations. Overlapping DNA fragments, amplified by one single cycling protocol from frozen pre-formulated PCR mixes, were subjected to DHPLC analysis. Single DHPLC injections of fragments yielded straightforward interpretation of results with a detection limit down to 1% mtDNA heteroplasmy. Furthermore, collection and re-amplification of low degree heteroduplex peak-fractions allowed sequence analysis of mtDNA mutations down to the detection limit of the DHPLC method. In order to demonstrate that the method has diagnostic value, we analyzed and confirmed known mtDNA mutations in patient samples.     

DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2

Denaturing high-performance liquid chromatography (DHPLC) is an efficient method for detection of mutations involving a single or few numbers of nucleotides, and it has been successfully used for mutation detection in disease-related genes. Colorectal cancer is one of the most common cancers, and mutations in the genes for hereditary nonpolyposis colon cancer (HNPCC), hMLH1 and hMSH2, also involve mainly point mutations. Sequence analysis is supposed to be a screening method with high sensitivity; however, it is time-consuming and expensive. We therefore decided to test sensitivity and reproducibility of DHPLC for 71 sequence variants in hMLH1 and hMSH2 initially found by sequence analysis in DNA samples of German HNPCC patients. DHPLC conditions of the PCR products were based on the melting pattern of the wild-type sequence of the corresponding PCR fragments. All but one of the 71 mutations was detected using DHPLC (sensitivity of 97%). Running time per sample averaged only 7 min, and the system is highly automated. Thus DHPLC is a rapid and sensitive method for the detection of hMLH1 and hMSH2 sequence variants.     

Denaturing HPLC-based approach for detection of COL7A1 gene mutations causing dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa (DEB) is a rare clinically heterogeneous genodermatosis due to genetic defects in type VII collagen gene (COL7A1). Identification of COL7A1 mutations is a challenge since this gene comprises 118 exons and more than 300 mutations scattered over the gene have been reported. Here, we describe for the first time the use of denaturing high performance liquid chromatography (DHPLC) for COL7A1 mutation detection. To validate the method, exon-specific DHPLC conditions were applied to screen DNA samples from patients carrying known COL7A1 mutations. Abnormal DHPLC profiles were obtained for all known mutations. Subsequent DHPLC analysis of 17 DEB families of unknown genotype allowed the identification of 21 distinct mutations, 9 of which were novel. The DHPLC mutation detection rate was significantly higher compared with our mutation scanning rate with conventional techniques (97% vs 86%), indicating DHPLC as the method of choice for COL7A1 molecular characterization in DEB patients.     

Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease

Denaturing high-performance liquid chromatography (DHPLC) is a relatively new technique, which utilizes heteroduplex formation between wild-type and mutated DNA strands to identify point mutations. Heteroduplex molecules are separated from homoduplex molecules by ion-pair, reverse-phase liquid chromatography on a special column matrix with partial heat denaturation of the DNA strands. In order to investigate the application of this method for point mutation detection in drug-resistant genes of Mycobacterium tuberculosis, katG, rpoB, embB, gyrA, pncA and rpsL genes, which are responsible for isoniazid, rifampicin, ethambutol, fluoroquinolone, pyrazinamide and streptomycin resistance, respectively, were detected by temperature-mediated DHPLC in 10 multidrug-resistant and 10 drug-susceptible clinical isolates. The DHPLC data were compared with those from a conventional MIC test. The results show that DHPLC is cost-effective with high capacity and accuracy, and is potentially useful for genotypic screening for mutations associated with anti-tuberculosis drug resistance.     

Mutation detection in the human HSP7OB' gene by denaturing high-performance liquid chromatography

Variances, particularly single nucleotide polymorphisms (SNP), in the genomic sequence of individuals are the primary key to understanding gene function as it relates to differences in the susceptibility to disease, environmental influences, and therapy. In this report, the HSP70B' gene is the target sequence for mutation detection in biopsy samples from human prostate cancer patients undergoing combined hyperthermia and radiation therapy at the Dana-Farber Cancer Institute, using temperature-modulated heteroduplex analysis (TMHA). The underlying principles of TMHA for mutation detection using DHPLC technology are discussed. The procedures involved in amplicon design for mutation analysis by DHPLC are detailed. The melting behavior of the complete coding sequence of the target gene is characterized using WAVEMAKER software. Four overlapping amplicons, which span the complete coding region of the HSP70B' gene, amenable to mutation detection by DHPLC were identified based on the software-predicted melting profile of the target sequence. TMHA was performed on PCR products of individual amplicons of the HSP70B' gene on the WAVE Nucleic Acid Fragment Analysis System. The criteria for mutation calling by comparing wild-type and mutant chromatographic patterns are discussed.     

Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations

Denaturing high-performance liquid chromatography (DHPLC) is a recently developed method of comparative sequencing based upon heteroduplex detection. To assess the reliability of this method, 180 different mutations (54 deletions, 12 insertions, and 117 single base substitutions) in BRCA1 and BRCA2 were tested. Second, 25 index individuals with complete DHPLC analysis of BRCA1 were reanalyzed by dye-terminator sequencing. Third, 41 index individuals were analyzed concomitantly by both DGGE and DHPLC. Of the 180 different BRCA1 and BRCA2 mutations, 179 showed heterozygous DHPLC elution profiles. Dye-terminator sequencing of the entire BRCA1 gene, including 5592 bp of coding sequence and 5206 bp of flanking noncoding sequence, in 25 index individuals did not reveal additional variants missed by DHPLC. The concomitant analysis of 41 index cases showed that 4 probably disease-associated mutations were identified by DHPLC while only 3 of those 4 sites were detected by denaturing gradient gel electrophoresis. We conclude that DHPLC is a sensitive and cost-effective method for the screening of BRCA1 and BRCA2.     

DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations

In order to evaluate the sensitivity and specificity of the recently introduced high-throughput method DHPLC (denaturing high performance liquid chromatography) for mutation screening in the VHL tumor suppressor gene, we subjected DNA from 43 unrelated VHL patients with previously sequenced VHL germline mutations to this method. In addition, 36 genomic DNAs of unrelated individuals suspected of being VHL carriers but with unknown germline status were analyzed by DHPLC and sequencing. The aims of the present study were to compare mutation results obtained by direct sequencing and DHPLC, and a comparison of two different DHPLC systems. The sensitivity of DHPLC was tested with two commercial devices and protocols, i.e., the Varian-Helix system and the Wave Nucleic Acid Fragment Analysis system. Both resolved all but one mutation in exons 2 and 3 of the VHL gene. In contrast, the GC-rich exon 1 showed discrepancies in the rate of mutation detection. Whereas the Varian-Helix system detected 10/15 (67%) of the known mutations, the Wave Nucleic Acid Fragment Analysis system detected 13/14 (93%). All three mutations in samples with unknown mutation status were revealed by both systems raising the mutation detection rate to 72% and 94%, respectively. Cases with different substitutions at the same nucleotide showed different elution profiles, but similar elution profiles could be obtained from different mutations. The Wave Nucleic Acid Fragment Analysis system detected most VHL mutations; however, when a 100% detection rate is needed, sequencing is still required and must therefore be the standard VHL mutation detection procedure. Once a family-specific mutation has been established, DHPLC may be suitable for the rapid and cost-effective determination of VHL carrier status in family members.     

Use of fluorescent DNA-intercalating dyes in the analysis of DNA via ion-pair reversed-phase denaturing high-performance liquid chromatography

SYBR Green 1 is an asymmetrical cyanine DNA-binding dye that provides an opportunity for increasing the sensitivity of nucleic acid detection when used in conjunction with gel electrophoresis. In this paper, we summarize the general properties and specific uses of SYBR green 1 in ion-pair reversed-phase denaturing high-performance liquid chromatography (IP DHPLC). We describe several applications for the WAVE DHPLC platform that illustrate the generic potential of such intercalating dyes in mutation detection and gene expression profiling. We show that SYBR Green 1 obviates the need to use end-labeled oligodeoxynucleotides for the sensitive detection of nucleic acids during chromatography. Moreover the incorporation of SYBR Green 1 into samples and elution buffers does not impair resolution and has no significant effect on the retention times of DNA fragments compared with dye-free DHPLC.     

应用变性高效液相色谱技术建立胸苷酸合成酶基因多态检测平台

TS基因5′非翻译区(5′ untranslation region, 5′UTR)增强子区域(TS enhancer region, TSER)存在28 bp的2次(2R)、3次(3R)的串联重复多态, 在3R等位基因第二次重复中还存在一个G→C的单核苷酸多态性(single nucleotide polymorphisms, SNPs), 同时在3′非翻译区(3′ untranslation region, 3′ UTR)存在6个碱基片段缺失/插入多态。这些多态形式的存在影响了TS基因mRNA的稳定和翻译效率, 并可导致不同TS基因型肿瘤患者对以5-fuorouracil (5-FU)为基础的化疗疗效产生差异。为提高TS基因型临床检测的效率和准确性, 方便、快捷、准确和自动化区分各种纯合及杂合基因型, 设计多重PCR反应, 同时扩增TS基因5′ 和3′ 非翻译区多态所处片段。利用DHPLC技术建立TS基因多态性检测平台, 在非变性条件下, 通过优化DHPLC 洗脱梯度, 同时检测5′ TSER区的串联重复多态和3′ UTR片段长度多态; 在变性条件下, 检测5′ TSER区单核苷酸多态。同时采用PCR-RFLP和DNA 测序方法, 验证DHPLC分析结果。